Other grades of this product :
| NIDA-41020 Basic information |
| Product Name: | NIDA-41020 | | Synonyms: | N-(Piperidin-1-yl)-5-(4-methoxyphenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide;1H-Pyrazole-3-carboxamide, 1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-4-methyl-N-1-piperidinyl-;NIDA-41020 >=97% (HPLC), solid | | CAS: | 502486-89-7 | | MF: | C23H24Cl2N4O2 | | MW: | 459.37 | | EINECS: | | Product Categories: | | Mol File: | 502486-89-7.mol |
| NIDA-41020 Chemical Properties |
| storage temp. | 2-8°C | | solubility | DMSO: ~16mg/mL | | form | solid | | color | off-white |
| Hazard Codes | T | | Risk Statements | 25-36/37/38 | | Safety Statements | 26-45 | | RIDADR | UN 2811 6.1 / PGIII | | WGK Germany | 3 |
| NIDA-41020 Usage And Synthesis |
| Uses | NIDA 41020 is an analog of rimonabant, which is a CB1 cannabinoic receptor antagonist that diminishes the behavioral effects of opiates and nicotine. | | Biochem/physiol Actions | NIDA-41020 is a CB1 cannabinoid receptor antagonist. NIDA-41020 is structurally similar to Rimonabant, which is currently in clinical development. NIDA-41020 is less lipophilic; developed at NIDA as a potential radioligand for CB1 receptors, Ki = 4.1 nM [in comparison AM 251, AM 281, SR 141716 (Rimonabant) have Ki of 0.6, 4.5 and 1.8 nM respectively]. |
| NIDA-41020 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye